A James R. Moriarty case site. Visit Moriarty.com for more information.
DePuy Hip Recall
Stay Informed In The News Crib Sheets Our Attorneys FAQs
Share

Recall of Artificial Hip Causes Johnson & Johnson 2012 Earnings Forecast to Dip 

February 20, 2012

Introduction

The pharmaceutical giant, Johnson & Johnson, has been given a 2012 earnings forecast which is below the previous estimates present by financial analysts due to the number of DePuy hip replacements which were recalled.  In fact, recent reports state Johnson & Johnson takes $3 billion charge for hip recall.  In 2010 it was discovered that the DePuy metal-on-metal hip replacement devices were shedding metal fragments and Johnson & Johnson issued a recall for those particular hip replacements. The metal fragments which were shed into the body were found to cause disabling injuries in some recipients, and the toxicity from the chromium and cobalt debris can cause the surrounding tissues to suffer necrosis or death.

Years of Potential Exposure to Toxic Metals for Hip Implant Recipients

Because the DePuy implants were specifically designed for younger patient, these recipients may be exposed to the toxic metals for many years. Many of the lawsuits currently being filed allege that Johnson & Johnson should have recalled the devices much sooner and that they continued to sell the hip implants long after they were aware of the unusually high failure rate. As early as 2008 Johnson & Johnson received complaints regarding loosening parts, infections, sensitivity to the metals of the implant, dislocated hips and fractures, and DePuy’s own internal data revealed a 12% revision surgery rate for the resurfacing system and a 13% rate for the ASR XL.

Johnson & Johnson Reports Higher than Expected Fourth Quarter Earnings

Fourth-quarter charges have allowed funds in the amount of $800 million dollars to be set aside for the patients and their attorneys who are involved in the DePuy hip replacement lawsuit. Analysts are unable to determine just how high the eventual costs will be as there are strong indications that more lawsuits are to come. The 2012 Johnson & Johnson corporate earnings forecast was between $5.05 and $5.15 per share as opposed to the Wall Street view of $5.21 per share. Despite the DePuy hip extensive recall, Johnson & Johnson reported higher than expected fourth-quarter earnings due largely to the sale of new prescription drugs and favorable corporate taxation.  When all was said and done, Johnson & Johnson earned $218 million dollars in their fourth quarter alone, which translated into approximately 8 cents per share.

Rise in Global Sales Due to New Drug Applications

Johnson & Johnson, based out of New Jersey, reported that global sales rose 3.9% in the fourth quarter of 2011, or $16.26 billion dollars, yet the company was only able to net $218 million of that due to the product recalls, litigation and patent battles currently waged against them. Johnson & Johnson is waiting to hear from the FDA regarding their new drug application for Xarelto, an oral anticoagulant meant to lower cardiovascular events for those who suffer from acute coronary syndrome as well as an application for Nucynta, an oral analgesic for neuropathic pain in diabetics.   

Corporate Profits vs. Patient Suffering

Johnson & Johnson reported spending some $109 million dollars in DePuy hip recall litigation expenses during the third quarter of 2011, while still managing to bring in over $1.3 billion dollars in worldwide sales of orthopedic joint replacements. This level of profit feels like a slap in the face to the thousands of patients who are currently suffering from implantation of a DePuy metal-on-metal hip replacement. These patients are dealing with chronic pain and an uncertain future while DePuy, the subsidiary of Johnson & Johnson racks up sales and income.

Anyone who has undergone a DePuy metal-on-metal hip replacement and suffered negative health issues as a result should contact an experienced product liability attorney as soon as possible to ensure their subsequent surgeries and medical expenses are fully covered. Should you decide to pursue a DePuy hip replacement lawsuit, an experienced attorney can ensure your rights are protected.


    Contact Us

    If you think you have a DePuy hip implant and would like to know more about the case, give our offices a call at 1-800-677-7095. Our people are standing by to answer your questions and explain how we can help.


    DePuy Crib Sheets

    Deciding what you want to do in the aftermath of this hip recall is extremely difficult. There are important medical and legal decisions to make, and you may not be feeling up to the task of figuring out the right questions to ask. We thought we'd try to make that a little easier for you.

    Medical Crib Sheets
    Legal Crib Sheets

    Learn more about the DePuy Hip Recall Cheat Sheets or just go right ahead and download them - they're absolutely free and we hope they help during this difficult time.

    DePuy Recall In The News

    As new updates appear in the news on the DePuy hip recall and the ASR XL Acetabular System, we put those links up here so you can stay informed. If you'd like to be notified when we have news updates, please subscribe to our feed.

    August 22, 2012
    Johnson & Johnson Agrees to Pay About $200,000 Per Case to Settle Three ASR Lawsuits in Nevada
    www.washpost.bloomberg.com

    June 27, 2012
    FDA Holds Hearing on Metal Hips But Dodges Fundamental Question of Inadequacy of Testing 
    www.nytimes.com

    March 12, 2012
    Too Little Too Late? Researchers Conclude Metal on Metal Hip Replacements Should Not Be Used.
    www.bbc.co.uk

    »Read our complete archive of articles about the Depuy hip recall.

    Have Questions?

    We've got answers. We've compiled a list of the most frequently asked questions we receive from incoming clients and given you our most informed answers. We explain the lawsuit, why you don't need to spend any money to hire an attorney, and the risks to your health.

    You can also browse our Stay Informed section for full articles on the case against DePuy and the medical problems with the ASR XL Acetabular total hip replacement system, or contact us directly.

    View our FAQs on the DePuy hip recall.

    Contact Information